A comprehensive view of Insulet Corp.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Sustainability & Social Responsibility Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Insulet receives CE mark approval for Abbott FreeStyle Libre 2 Plus sensor compatibility with Omnipod 5 Automated Insulin Delivery System for type 1 diabetics; company planning a phased launch starting in UK and Netherlands in 2024
Published: February 07, 2024 by Associated Press
Baird: Early data suggest GLP-1 weight-loss drugs like Ozempic can drive type-2 diabetes into remission; if fewer patients need an insulin pump to put insulin into the body, companies like Tandem Diabetes Care and Insulet could be hit hard
Published: October 18, 2023 by Business Insider
FDA clears Insulet's Omnipod GO, a tubeless, waterproof wearable insulin delivery device for adults with type 2 diabetes; device offers an alternative to daily injections and helps patients transition to insulin therapy
Published: April 28, 2023 by Drug Topics

Ask us about our Sustainability & Social Responsibility market view

Trending Chart

Interactive chart with headline count